Controlled circumferential renal sympathetic denervation with preservation of the renal arterial wall using intraluminal ultrasound: A next-generation approach for treating sympathetic overactivity

EuroIntervention

Volumn 10, Issue 10, 2015, Pages 1230-1238

  Sakakura, Kenichi ^a   Roth, Austin ^b   Ladich, Elena ^a   Shen, Kai ^a   Coleman, Leslie ^b   Joner, Michael ^a   Virmani, Renu ^a  

^a CVPATH INSTITUTE   (United States)

^b ReCor Medical Inc   (United States)

Author keywords

Catheter; Pathology; Renal artery; Renal sympathetic denervation; Ultrasound

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; GEL;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATHETER; CATHETER ABLATION; CONTROLLED STUDY; ECHOGRAPHY; GUIDING CATHETER; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY DENERVATION SYSTEM; MORPHOMETRICS; NONHUMAN; PHANTOM; PIEZOELECTRICITY; RENAL ARTERY; SYMPATHETIC INNERVATION; TEMPERATURE; ANIMAL; AUDIOVISUAL EQUIPMENT; DEVICES; GEL; HYPERTENSION; IN VITRO STUDY; INNERVATION; KIDNEY ARTERY; PATHOLOGY; PIEZOSURGERY; PIG; PROCEDURES; SYMPATHECTOMY;

ANIMALS; CATHETER ABLATION; GELS; HYPERTENSION; IN VITRO TECHNIQUES; MODELS, ANATOMIC; PIEZOSURGERY; RENAL ARTERY; SWINE; SYMPATHECTOMY;

EID: 84924303076     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/eijy14m10_14     Document Type: Article

References (17)

1. James PA, Oparil S, Carter BL, Cushman WC, Dennison- Himmelfarb C, Handler J, Lackland DT, Lefevre ML, Mackenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-20.
2. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51:1403-19.
3. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension. 1999;34:724-8.
4. Schlaich MP, Schmieder RE, Bakris G, Blankestijn PJ, Bohm M, Campese VM, Francis DP, Grassi G, Hering D, Katholi R, Kjeldsen S, Krum H, Mahfoud F, Mancia G, Messerli FH, Narkiewicz K, Parati G, Rocha-Singh KJ, Ruilope LM, Rump LC, Sica DA, Sobotka PA, Tsioufis C, Vonend O, Weber MA, Williams B, Zeller T, Esler MD. International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension. J Am Coll Cardiol. 2013;62:2031-45.
5. Mahfoud F, Ewen S, Ukena C, Linz D, Sobotka PA, Cremers B, Bohm M. Expanding the indication spectrum: renal denervation in diabetes. EuroIntervention. 2013;9:R117-21.
6. Bohm M, Ewen S, Kindermann I, Linz D, Ukena C, Mahfoud F. Renal denervation and heart failure. Eur J Heart Fail. 2014;16:608-13.
7. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatmentresistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903-9.
8. Mabin T, Sapoval M, Cabane V, Stemmett J, Iyer M. First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension. EuroIntervention. 2012;8: 57-61.
9. National Research Council. Guide for the Care and Use of Laboratory Animals, 8th Edition. Washington, DC, USA: National Academies Press; 2011.
10. Sakakura K, Ladich E, Edelman ER, Markham P, Stanley JR, Keating J, Kolodgie FD, Virmani R, Joner M. Methodological Standardization for the Pre-Clinical Evaluation of Renal Sympathetic Denervation. JACC Cardiovasc Interv. 2014 Sep 9. [Epub ahead of print].
11. Sakakura K, Ladich E, Cheng Q, Otsuka F, Yahagi K, Fowler D, Kolodgie F, Virmani R, Joner M. Anatomical assessment of sympathetic peri-arterial renal nerves in man. J Am Coll Cardiol. 2014;64:635-43.
12. Koruth J, Dukkipati S, Miller M, Sinelnikov Y, Zou Y, Smith D, d'Avila A, Reddy VY. Selective Renal Sympathetic Denervation With Arterial Sparing?: An in vivo Proof of Principle Study Using Ultrasound Energy (Abstract). Circulation. 2011;124: A16042.
13. Wang Q, Guo R, Rong S, Yang G, Zhu Q, Jiang Y, Deng C, Liu D, Zhou Q, Wu Q, Wang S, Qian J, Wang Q, Lei H, He TC, Wang Z, Huang J. Noninvasive renal sympathetic denervation by extracorporeal high-intensity focused ultrasound in a preclinical canine model. J Am Coll Cardiol. 2013;61:2185-92.
14. Rippy MK, Zarins D, Barman NC, Wu A, Duncan KL, Zarins CK. Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety. Clin Res Cardiol. 2011;100:1095-101.
15. Steigerwald K, Titova A, Malle C, Kennerknecht E, Jilek C, Hausleiter J, Nahrig JM, Laugwitz KL, Joner M. Morphological assessment of renal arteries after radiofrequency catheter-based sympathetic denervation in a porcine model. J Hypertens. 2012;30: 2230-9.
16. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL; SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393-401.
17. Virmani R, Avolio AP, Mergner WJ, Robinowitz M, Herderick EE, Cornhill JF, Guo SY, Liu TH, Ou DY, O'Rourke M. Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities. Am J Pathol. 1991; 139:1119-29.